Teledermatology During COVID-19: An Updated Review
Morgan A. Farr, Madeleine Duvic, Tejas P. Joshi
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has fundamentally transformed the landscape of providing dermatologic care. In an age of lockdowns and social distancing, teledermatology (TD) has emerged as a powerful tool to deliver remote care. Here, we review literature on TD use during the pandemic to evaluate the positives and negatives of TD implementation. We especially consider the reception of TD in underserved communities and the developing world as well as the ethico-legal challenges wrought by the burgeoning utilization of this new paradigm of care. The potential of TD to occupy a more prominent role in dermatologic care in a post-COVID-19 world is also discussed.
Topics & Concepts
TeledermatologyPandemicCoronavirus disease 2019 (COVID-19)Social distanceMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMEDLINETelemedicineHealth careDiseaseVirologyPathologyPolitical scienceInfectious disease (medical specialty)LawOutbreakCutaneous Melanoma Detection and ManagementNonmelanoma Skin Cancer StudiesCutaneous lymphoproliferative disorders research